Yoshihiro Keto

513 total citations
23 papers, 443 citations indexed

About

Yoshihiro Keto is a scholar working on Surgery, Gastroenterology and Physiology. According to data from OpenAlex, Yoshihiro Keto has authored 23 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Gastroenterology and 6 papers in Physiology. Recurrent topics in Yoshihiro Keto's work include Helicobacter pylori-related gastroenterology studies (14 papers), Gastrointestinal motility and disorders (11 papers) and Complementary and Alternative Medicine Studies (5 papers). Yoshihiro Keto is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (14 papers), Gastrointestinal motility and disorders (11 papers) and Complementary and Alternative Medicine Studies (5 papers). Yoshihiro Keto collaborates with scholars based in Japan, United States and China. Yoshihiro Keto's co-authors include Masao Sasamata, Toshiyuki Funatsu, Shinobu Akuzawa, Satoru Takahashi, Takashi Uchiyama, Toshihide Yokoyama, Asako Yamamoto, Takuya Fujita, Tetsuya Hirata and Asako Takeuchi and has published in prestigious journals such as Gastroenterology, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Yoshihiro Keto

23 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshihiro Keto Japan 13 206 175 107 67 51 23 443
Koji Takeuchi Japan 11 212 1.0× 104 0.6× 89 0.8× 94 1.4× 17 0.3× 18 448
Michael Respondek Germany 13 267 1.3× 71 0.4× 118 1.1× 115 1.7× 16 0.3× 20 696
Misa Mizumori United States 11 165 0.8× 109 0.6× 66 0.6× 153 2.3× 9 0.2× 13 510
Konturek Sj Poland 14 332 1.6× 99 0.6× 74 0.7× 97 1.4× 22 0.4× 60 612
Nobuaki Nakamura Japan 7 93 0.5× 55 0.3× 71 0.7× 80 1.2× 11 0.2× 10 442
Judith M. Hills United Kingdom 8 108 0.5× 126 0.7× 51 0.5× 113 1.7× 4 0.1× 9 378
Angela Capriati Italy 10 77 0.4× 118 0.7× 62 0.6× 119 1.8× 2 0.0× 28 426
Robert E. Kraichely United States 11 222 1.1× 233 1.3× 79 0.7× 113 1.7× 4 0.1× 13 483
Piotr K. Zakrzewski Poland 13 66 0.3× 84 0.5× 124 1.2× 156 2.3× 2 0.0× 21 484
Pawlik Ww Poland 13 144 0.7× 31 0.2× 82 0.8× 84 1.3× 5 0.1× 29 406

Countries citing papers authored by Yoshihiro Keto

Since Specialization
Citations

This map shows the geographic impact of Yoshihiro Keto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Keto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Keto more than expected).

Fields of papers citing papers by Yoshihiro Keto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiro Keto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Keto. The network helps show where Yoshihiro Keto may publish in the future.

Co-authorship network of co-authors of Yoshihiro Keto

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiro Keto. A scholar is included among the top collaborators of Yoshihiro Keto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiro Keto. Yoshihiro Keto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keto, Yoshihiro, et al.. (2014). Inhibitory effect of the selective serotonin 5-HT3 receptor antagonist ramosetron on duodenal acidification-induced gastric hypersensitivity in rats. European Journal of Pharmacology. 731. 88–92. 6 indexed citations
2.
Kojima, Ryosuke, Katsura Nozawa, Hitoshi Doihara, et al.. (2013). Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain. European Journal of Pharmacology. 723. 288–293. 54 indexed citations
3.
Keto, Yoshihiro, et al.. (2012). Inhibitory effect of ramosetron on corticotropin releasing factor‐ and soybean oil‐induced delays in gastric emptying in rats. Journal of Gastroenterology and Hepatology. 27(9). 1505–1511. 12 indexed citations
4.
Keto, Yoshihiro, et al.. (2011). Influence of gastric acid on gastric emptying and gastric distension‐induced pain response in rats – effects of famotidine and mosapride. Neurogastroenterology & Motility. 24(2). 147–147. 9 indexed citations
6.
Keto, Yoshihiro, Asako Takeuchi, Toshiyuki Funatsu, et al.. (2008). Effects of serotonin 5-HT3 receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats. European Journal of Pharmacology. 587(1-3). 281–284. 13 indexed citations
8.
Hirata, Tetsuya, et al.. (2007). Pharmacological profile of ramosetron, a novel therapeutic agent for IBS. Inflammopharmacology. 15(1). 5–9. 21 indexed citations
9.
Keto, Yoshihiro, et al.. (2007). Evaluation of the Pharmacological Profile of Ramosetron, a Novel Therapeutic Agent for Irritable Bowel Syndrome. Journal of Pharmacological Sciences. 104(3). 263–273. 35 indexed citations
10.
Funatsu, Toshiyuki, et al.. (2007). Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats. European Journal of Pharmacology. 573(1-3). 190–195. 24 indexed citations
11.
Funatsu, Toshiyuki, et al.. (2006). Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated rats. European Journal of Pharmacology. 554(1). 53–59. 23 indexed citations
12.
Keto, Yoshihiro, et al.. (2002). Influence of Helicobacter pylori Infection on Healing and Relapse of Acetic Acid Ulcers in Mongolian Gerbils. Digestive Diseases and Sciences. 47(4). 837–849. 15 indexed citations
13.
Keto, Yoshihiro, et al.. (2001). EFFECTS OF INDOMETHACIN ON THE DEVELOPMENT OF ULCERS IN HELICOBACTER PYLORI-INFECTED MONGOLIAN GERBILS. 28(2). 195–197. 1 indexed citations
14.
Keto, Yoshihiro, et al.. (2001). Gastric mucosal changes induced by long term infection with Helicobacter pylori in Mongolian gerbils: effects of bacteria eradication. Journal of Physiology-Paris. 95(1-6). 429–436. 31 indexed citations
15.
Aihara, Takeshi, et al.. (2001). Effects of dexamethasone and FK506 on Helicobacter pylori-induced gastritis and bacterial viability in Mongolian gerbils. Journal of Physiology-Paris. 95(1-6). 443–451. 3 indexed citations
16.
Satake, Nobuhiro, et al.. (2000). The Inhibitory Effect of KT3-671, a Nonpeptide Angiotensin-Receptor Antagonist, on Rabbit and Rat Isolated Vascular Smooth Muscles: A Possible Involvement of KATP Channels. Journal of Cardiovascular Pharmacology. 35(3). 457–467. 3 indexed citations
17.
Satake, Nobuhiro, et al.. (2000). Genistein Potentiates the Relaxation Induced by β1- and β2-Adrenoceptor Activation in Rat Aortic Rings. Journal of Cardiovascular Pharmacology. 35(2). 227–233. 10 indexed citations
18.
Keto, Yoshihiro, Satoru Takahashi, & Susumu Okabe. (1999). Relapse of healed acetic acid-induced ulcers by Helicobacter pylori infection in Mongolia gerbils. The Japanese Journal of Pharmacology. 79. 54–54. 1 indexed citations
19.
Keto, Yoshihiro, et al.. (1999). Healing of Helicobacter pylori -Induced Gastric Ulcers in Mongolian Gerbils (Combined Treatment with Omeprazole and Clarithromycin). Digestive Diseases and Sciences. 44(2). 257–265. 26 indexed citations
20.
Takahashi, Satoru, et al.. (1998). Pathological Changes in the Formation of Helicobacter pylori-Induced Gastric Lesions in Mongolian Gerbils. Digestive Diseases and Sciences. 43(4). 754–765. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026